More attention should be paid to modifiable risk factors for chronic liver disease in people with HIV, such as alcohol, metabolic disorders and being overweight, HIV and hepatology specialists in Brighton, England report in the Journal of Acquired Immune Deficiency Syndromes.
In a study of people with HIV who had abnormally high liver enzyme levels, they found that one in five had clinically significant liver damage and 60% had risk factors that could be modified by treatment of metabolic complications and/or abstinence from alcohol.
They also found that past treatment with a first-generation antiretroviral drug, didanosine (ddI), increased the risk of both clinically significant fibrosis and moderate-to-severe fat accumulation in the liver.
Read the full story at Aidsmap.
Source : Aidsmap
Related HIV and Co-Infections News
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.